HLTT(.30)...post-merger details on the proposed SPK/Varian deal......
Although a date has not yet been set for the shareholder vote on the merger of SPK and Varian Biopharma, I think there is now a strong likelihood the merger will get approved. Most of the investors who wanted to cash-out of this particular SPAC probably already did it with the most recent extension vote. The amended S-4 that SPK filed last week contains enough information on pages 24/25 to do some reasonably accurate calculations on the private placement, final structure, and HLTT's ownership position.
It looks like they have made arrangements for an $11.8+M private placement at a price above $6.6, and the final share structure (including the private placement shares) will be in the range of 7.91M and 8.95M shares. HLTT will own a little over 246K shares (around 2.75-3.1%) of the post-merger company.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.